Remove 2013 Remove Marketing Remove Treatments
article thumbnail

Why Not All Olive Oils Are Created Equal And How to Choose the Best

Alison Bladh

The Truth About Olive Oil Quality Olive oil is often marketed as a "healthy fat," but what many people dont realise is that the quality can vary dramatically. How to Spot High-Quality Olive Oil With so many olive oils on the market, how do you ensure youre getting the best? TO MY HEALTH BITES TO MY WEBSITE References Estruch, R.,

Diet 97
article thumbnail

In-demand Devices

Aesthetics Exposed

The use of devices in esthetics can bring new life into a treatment room and is gaining popularity among clients. The marketing trends of esthetic modalities have clients seeking treatments with various skin rejuvenation devices. The treatment is simple if all the guidelines are followed including the use of eye protection.

Esthetics 195
article thumbnail

Is Age-Related Macular Degeneration (AMD) Preventable and Treatable With Supplements?

Aesthetics Advisor

Before the AREDS2 study finished, manufacturers began marketing supplements based on the study design. Progression to advanced AMD was established by examination of retina photographs or treatment for advanced AMD. JAMA, published online May 5, 2013. Lutein/Zeaxanthin for the Treatment of Age-Related Cataract.”

article thumbnail

Eczema & Steroids: Balancing Clear Skin Benefits with Potential Health Risks (2025)

Aesthetics Advisor

Kate stopped giving Alex topical steroids in June 2013. He was later prescribed UVB narrowband phototherapy, a treatment using UVB light to reduce skin inflammation. For decades, Rapaport has warned that prolonged topical steroid use can lead to stubborn, treatment-resistant eczema. Kates concerns are far from unique.

Eczema 36
article thumbnail

Biosimilar Watch: FDA Accepts BLA for Proposed Stelara Biosimilar 

The Dermatology Digest

Ustekinumab is approved for the treatment of plaque psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis. market during the next five years. As a global subsidiary of Intas Pharmaceuticals, Accord BioPharma will be responsible for U.S. commercialization. president of Accord, in a news release.

article thumbnail

TDD Industry News and Views: Weekly Updates on Comings, Goings, and Other Happenings in Dermatology

The Dermatology Digest

market is my primary objective. This market accounts for three-quarters of our addressable market making it the territory with the highest potential. PermeaDerm is cleared by the Food and Drug Administration as a transparent matrix for use in the treatment of a variety of wound types until healing is achieved.

article thumbnail

Balancing the Skin Biome

The Dermatology Digest

To find a way to curate that beneficial strain, Dr. Hitchcock founded Xycrobe Therapeutics in 2013. The Xycrobe research group examined the use of those genetically modified microbes vs microbes alone in both animal and human trials for the treatment of psoriasis. 2013 Apr 30;4(3):e00003-13. doi: 10.1128/mBio.00003-13.